Bio-IT World, San Diego, CA,
Discussion Moderator: Bernard P. Wess, President
Summary:
Life Sciences companies
generate enormous numbers of documents and amounts of data. Market information, regulatory
documentation, disease management, clinical trials, detailed research and
development and finally, medical records and claims data and documents must all
be integrated. According to PwC, full
data integration will facilitate:
Better compliance and faster
regulatory approval
Creating a management
environment of flexible and adaptive decision making by utilizing scenario
planning
Using predictive market modeling
and simulation to develop small market segments, new pharmaceuticals and
devices
Monitoring a global
“e-environment” of markets, research and development
Tracking and documenting
emerging trends and competitive threats
Better allocations of internal
and partner resources
Adaptive experimentation in
marketing, i.e., electronic CRM for patients
Real-time management review
and iteration of decisions